Beta-1 Adrenergic Receptor Protein
Introduction
Beta 1 Adrenergic Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ADRB1 Protein - Beta-1 Adrenergic Receptor Protein [@bachman2002]
<div class="infobox infobox-protein"> [@yu2014]
<div class="header">Protein Information</div> [@qian2015]
<table> [@flaherty2013]
<tr><td><b>Protein Name</b></td><td>Beta-1 Adrenergic Receptor Protein</td></tr>
<tr><td><b>Gene</b></td><td>[ADRB1](/genes/adrb1)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P08588](https://www.uniprot.org/uniprotkb/P08588/entry)</td></tr>
<tr><td><b>PDB ID</b></td><td>2VT4</td></tr>
<tr><td><b>Molecular Weight</b></td><td>51 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cell membrane, heart and CNS</td></tr>
<tr><td><b>Protein Family</b></td><td>Adrenergic receptor (Class A, GPCR)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Structure
Beta-1 receptor has the typical 7-transmembrane domain structure with an extracellular N-terminus and intracellular C-terminus. It contains the DRY motif at the end of TM3 and forms both monomers and dimers. The ligand binding pocket is located within the transmembrane domains.
Normal Function
...Beta-1 Adrenergic Receptor Protein
Introduction
Beta 1 Adrenergic Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ADRB1 Protein - Beta-1 Adrenergic Receptor Protein [@bachman2002]
<div class="infobox infobox-protein"> [@yu2014]
<div class="header">Protein Information</div> [@qian2015]
<table> [@flaherty2013]
<tr><td><b>Protein Name</b></td><td>Beta-1 Adrenergic Receptor Protein</td></tr>
<tr><td><b>Gene</b></td><td>[ADRB1](/genes/adrb1)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P08588](https://www.uniprot.org/uniprotkb/P08588/entry)</td></tr>
<tr><td><b>PDB ID</b></td><td>2VT4</td></tr>
<tr><td><b>Molecular Weight</b></td><td>51 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cell membrane, heart and CNS</td></tr>
<tr><td><b>Protein Family</b></td><td>Adrenergic receptor (Class A, GPCR)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Structure
Beta-1 receptor has the typical 7-transmembrane domain structure with an extracellular N-terminus and intracellular C-terminus. It contains the DRY motif at the end of TM3 and forms both monomers and dimers. The ligand binding pocket is located within the transmembrane domains.
Normal Function
The beta-1 adrenergic receptor is a Gs protein-coupled receptor that stimulates adenylyl cyclase, increasing intracellular cAMP levels. It mediates the effects of epinephrine and norepinephrine on cardiac function (increased heart rate and contractility), lipolysis, and thermogenesis. In the brain, it plays roles in attention, memory consolidation, and stress responses.
Role in Disease
Beta-1 receptors are important in [Parkinson's disease](/diseases/parkinsons-disease) and [Alzheimer's disease](/diseases/alzheimers-disease) through effects on neuroinflammation and cerebral blood flow. Beta-blockers are used in cardiovascular disease but may have cognitive effects in older adults. The receptor may influence neurodegeneration through adrenergic signaling in the brain.
Therapeutic Targeting
Beta-1 selective antagonists (metoprolol, atenolol, bisoprolol) are first-line treatments for hypertension and heart failure. In neurodegenerative diseases, beta-blockers are being investigated for their potential neuroprotective effects through reduction of neuroinflammation.
Expression Pattern
The ADRB1 receptor exhibits a distinct expression pattern across various tissues and brain regions. In the heart, ADRB1 is highly expressed in cardiac myocytes where it mediates the positive chronotropic and inotropic effects of catecholamines. In the central nervous system, ADRB1 expression has been detected in several key regions including:
- Cerebral [cortex](/brain-regions/cortex): Moderate expression in pyramidal [neurons](/entities/neurons), particularly layer 5
- [Hippocampus](/brain-regions/hippocampus): Expression in CA1 and CA3 pyramidal neurons
- Cerebellum: Presence in Purkinje cells and granule cell layer
- Hypothalamus: Regulation of sympathetic outflow
- Locus coeruleus: Interaction with noradrenergic system
Peripheral expression includes adipose tissue, kidney, and skeletal muscle where ADRB1 plays roles in lipolysis, renin secretion, and glycogenolysis respectively.
Signal Transduction Mechanisms
ADRB1 activates multiple intracellular signaling cascades through coupling to Gαs proteins:
cAMP/PKA pathway: Activation of adenylate cyclase increases cAMP levels, activating protein kinase A (PKA)
ERK1/2 activation: Can occur through both cAMP-dependent and independent mechanisms
Calcium handling: Modulation of L-type calcium channels and phospholamban phosphorylation
Gene transcription: CREB-mediated transcription of survival genesAnimal Models
Several animal models have been developed to study ADRB1 function:
- Adrb1 knockout mice: Show bradycardia and reduced cardiac stress response
- Conditional knockout models: Brain-specific deletion reveals role in cognition
- Transgenic overexpression: Cardiac-specific overexpression leads to cardiomyopathy
- Conditional KO: Allows temporal control of gene deletion
Research Directions
Current research focuses on:
- biased agonism: Developing ligands that activate specific signaling pathways
- oligomerization: Understanding receptor dimer formation and function
- spatial pharmacology: Targeting specific neuronal populations
- circadian regulation: ADRB1 expression shows diurnal variation
- sex differences: Understanding gender-specific responses to beta-blockers
Background
The study of Beta 1 Adrenergic Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Genes Index](/genes)
- [Glutamate Receptors](/mechanisms/glutamatergic-signaling)
- [Serotonin Signaling](/mechanisms/serotonin-signaling)
- Adrenergic Receptors
- [GPCR Signaling](/mechanisms/gpcr-signaling)